Evidence supporting the current management guidelines for high-grade squamous intraepithelial lesion cytology. J Low Genit Tract Dis 2004 Apr;8(2):139-46
Date
05/06/2005Pubmed ID
15874852DOI
10.1097/00128360-200404000-00010Scopus ID
2-s2.0-16544375183 (requires institutional sign-in at Scopus site) 4 CitationsAbstract
OBJECTIVE: The study was undertaken to provide consensus guidelines for the management of women with a cytologic interpretation of high-grade squamous intraepithelial lesion (HSIL) on cytologic examination. This review article presents relevant literature supporting the proposed guidelines.
PARTICIPANTS: An independent panel of 121 experts in various aspects of the diagnosis and management of cervical cancer precursors, including representatives from 29 participating professional organizations, federal agencies, national and international health organizations, and others were invited by the American Society for Colposcopy and Cervical Pathology.
CONSENSUS PROCESS: Guidelines for the management of women with HSIL cytologic results were developed through a multistep process. Draft management guidelines were developed by the HSIL working group after formal literature reviews and obtained input from the professional community at large by way of an interactive internet-based bulletin board. At the American Society for Colposcopy and Cervical Pathology Consensus Conference, September 6 through 8, 2001, in Bethesda, Maryland, the guidelines were discussed, revised, and adopted by formal vote.
CONCLUSIONS: Evidence-based guidelines have been developed for the management of women with HSIL cytologic results.